InvestorsHub Logo
Followers 79
Posts 24445
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 05/11/2022 8:40:21 AM

Wednesday, May 11, 2022 8:40:21 AM

Post# of 27348
RGLS - .1718 Pre-market .193/.1995

Regulus Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

https://stockcharts.com/h-sc/ui?s=rgls

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.